ERS Congress 2026

BOSTON — September 8, 2026 Avalyn Pharma presented new data at the European Respiratory Society (ERS) International Congress 2026...

ALDERLEY PARK, Cheshire, U.K. — September 8, 2026 Infex Therapeutics presented new data from its Phase IIa study of...

WALTHAM, Mass. — September 8, 2026 Upstream Bio, Inc. presented results from the Phase 2 VALIANT trial of verekitug...

Basel, Switzerland / London, UK / New York, NY — September 6, 2026 Roivant and Pulmovant announced that topline...

Bridgewater, New Jersey, USA, September 3, 2026 Insmed Incorporated announced that five abstracts from its respiratory portfolio have been...

YARDLEY, Pa., August 24, 2026 Savara Inc. will present new and previously reported Phase 3 IMPALA-2 clinical trial data...

Alderley Park, Cheshire, U.K., August 19, 2026 Infex Therapeutics will present new Phase IIa data for RESP-X (INFEX702) in...